Table 1.
Correlation of clinical parameters with overall survival; na = not available
| Patient characteristics | Number of patients (n = 78) | Mean overall Survival (months) | p-value |
|---|---|---|---|
| Gender | 0.37 | ||
| Male | 54 | 43.07 | |
| Female | 24 | 49.62 | |
| Age at operation | 0.514 | ||
| <median = 64 years | 37 | 43.82 | |
| ≥ median = 64 years | 41 | 42.68 | |
| Anastomotic leakage | 0.841 | ||
| Yes | 7 | 50.10 | |
| No | 71 | 44.42 | |
| T-Stage | 0.495 | ||
| T1 | 2 | na | |
| T2 | 8 | 32.8 | |
| T3 | 54 | 40.04 | |
| T4 | 14 | 38.28 | |
| N-Stage | 0.08 | ||
| N0 | 30 | 49.18 | |
| N1 | 30 | 37.82 | |
| N2 | 18 | 41.79 | |
| M-Stage | 0.01 | ||
| M0 | 55 | 46.69 | |
| M1 | 23 | 36.55 | |
| Occurrence of liver metastases | 0.002 | ||
| Liver metastases (synchronous and metachronous) | 26 | 35.53 | |
| No liver metastases | 52 | 51.51 | |
| Resection margin status | 0.121 | ||
| R0 | 68 | 45.98 | |
| R1 | 4 | 35.25 | |
| Rx | 6 | 29.02 | |
| Grading | 0.708 | ||
| G1 | 0 | ||
| G2 | 54 | 43.55 | |
| G3 | 23 | 45.97 | |
| Data not available | 1 | ||
| Adjuvant chemotherapy | 0.083 | ||
| Yes | 47 | 40.66 | |
| No | 31 | 44.20 |